Naproxen 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Reported: July 17, 2013 Initiated: May 29, 2013 #D-762-2013
Product Description
Naproxen 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Reason for Recall
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Details
- Recalling Firm
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
- Units Affected
- 1
- Distribution
- Nationwide and PR
- Location
- Orlando, FL
Frequently Asked Questions
What product was recalled? ▼
Naproxen 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL. Recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy. Units affected: 1.
Why was this product recalled? ▼
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on July 17, 2013. Severity: Moderate. Recall number: D-762-2013.
Related Recalls
FDA Drug Moderate
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…
Unichem Pharmaceuticals USA Inc. · 2026-02-11
FDA Drug Critical
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…
Green Lumber Holdings, LLC · 2026-02-11
FDA Drug Moderate
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…
Granules Pharmaceuticals Inc. · 2026-02-11
FDA Drug Critical
Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11
FDA Drug Critical
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
HANDELNINE GLOBAL LLC · 2026-02-11